Electroencephalography

Emotion Detection and Recognition Market with COVID-19 Analysis, by Component, Application Area, End-user, Vertical, and Region - Global Forecast to 2027

Retrieved on: 
Friday, April 22, 2022
Deep learning, ECG, Gesture, Compound annual growth rate, Adoption, EEG, COVID-19, Automotive industry, ML, Software, CAGR, Component, Region, Biosensor, EMG, AI, USD, IOT, Asia-Pacific, Globe, Video game, Medical device, Medical imaging, Vertical, Electroencephalography, Electromyography, Electrocardiography

DUBLIN, April 22, 2022 /PRNewswire/ -- The "Global Emotion Detection and Recognition Market with COVID-19 Analysis, by Component (Software [Facial Expression Recognition, Speech & Voice Recognition], Services), Application Area, End-user, Vertical, and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, April 22, 2022 /PRNewswire/ -- The "Global Emotion Detection and Recognition Market with COVID-19 Analysis, by Component (Software [Facial Expression Recognition, Speech & Voice Recognition], Services), Application Area, End-user, Vertical, and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global emotion detection and recognition market is projected to grow from USD 23.6 billion in 2022 to USD 43.3 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 12.9% during the forecast period.
  • APAC constitutes major economies, such as China, Japan, and Australia, which are expected to register high growth rates in the emotion detection and recognition market.
  • End-users, such as industrial, commercial, and enterprises are expected to adopt emotion detection and recognition solutions at the highest rate in the region.

Global Emotion Detection and Recognition Market (2022 to 2027) - Growing Partnerships and Widening Ecosystems Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 20, 2022
Technology, Software, Deep learning, ECG, Gesture, Compound annual growth rate, Adoption, EEG, COVID-19, Automotive industry, ML, Software, CAGR, Component, Region, Biosensor, EMG, AI, USD, IOT, Asia-Pacific, Globe, Video game, Medical device, Medical imaging, Vertical, Electroencephalography, Electromyography, Electrocardiography

The "Global Emotion Detection and Recognition Market with COVID-19 Analysis, by Component (Software [Facial Expression Recognition, Speech & Voice Recognition], Services), Application Area, End-user, Vertical, and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Emotion Detection and Recognition Market with COVID-19 Analysis, by Component (Software [Facial Expression Recognition, Speech & Voice Recognition], Services), Application Area, End-user, Vertical, and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global emotion detection and recognition market is projected to grow from USD 23.6 billion in 2022 to USD 43.3 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 12.9% during the forecast period.
  • APAC constitutes major economies, such as China, Japan, and Australia, which are expected to register high growth rates in the emotion detection and recognition market.
  • End-users, such as industrial, commercial, and enterprises are expected to adopt emotion detection and recognition solutions at the highest rate in the region.

Nihon Kohden America Launches Life Scope® G5 and G5Max

Retrieved on: 
Monday, April 4, 2022
General Health, Health, Other Health, Medical Devices, Electroencephalography, CEO, EGG, Software, Technology, Review, Ecosystem, Efficiency, Patient, QT interval, Pharmaceutical industry, Medical device

Nihon Kohden America, a global leader in precision medical products and services, today announced the expansion of the Life Scope G Series with the US market introduction of Life Scope G5 and G5Max, a new series of bedside monitoring systems.

Key Points: 
  • Nihon Kohden America, a global leader in precision medical products and services, today announced the expansion of the Life Scope G Series with the US market introduction of Life Scope G5 and G5Max, a new series of bedside monitoring systems.
  • The advanced features of Life Scope G5 and G5Max combine fully optimized, adaptable monitors with an enterprise level server and software applications customized to the needs of clinicians.
  • Both Life Scope G5 and G5Max allow users to configure the alarms to meet their clinical needs and reduce alarm fatigue.
  • The Life Scope G5 and G5Max offer advanced EGG parameter monitoring such as continuous QTc or QRSd, advanced atrial fibrillation algorithm, enhanced review capability ST analysis and event recall.

Electroencephelographs (EEG) Pipeline Insight and Competitive Landscape Report 2022: Comprehensive Insights About 20+ Companies and 20+ Pipeline Devices - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 31, 2022
Medical Devices, Health, Clinical professor, Therapy, Lists of diseases, PSG, Diagnosis, CE, Market entry strategy, Growth, Electroencephalography, Competitive landscape, Patient, Research, Incidence, Functional neuroimaging, Parkinson's disease, Seizure, Endophenotype, Prevalence, Schizophrenia, Multi, Channel, Injury, Alzheimer's disease, Mayo Clinic, Electrode, Review, Stroke, NIH, EEG, Epilepsy, BRAIN, News, Awareness, FDA, Acquisition, Multiple sclerosis, Oil, Medical device, Dementia, Borealis

This "Electroencephelographs (EEG)-Pipeline Insight and 2022" report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Electroencephelographs pipeline landscape.

Key Points: 
  • This "Electroencephelographs (EEG)-Pipeline Insight and 2022" report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Electroencephelographs pipeline landscape.
  • This report provides a detailed study of the emerging Electroencephelographs devices along with competitive landscape to help better understand the emerging Electroencephelographs devices.
  • Electroencephelographs can divided based on Types - Standalone devices and Portable devices- both are covered in this report.
  • Electroencephelographs can be divided based on Channels - 8-channel EEG, 21-channel EEG, 25 channel EEG, 32-channel EEG, 40-channel EEG, Multi-channel EEG.

Second Annual World Coma Day Signals Awakening Hope for Coma as a Treatable and Recoverable Condition

Retrieved on: 
Wednesday, March 16, 2022
Science, Other Science, Biotechnology, Research, Managed Care, General Health, Health, Clinical Trials, Rehabilitation, Prognosis, University, Neuroscience, Patient, NCS, Brain, Review, Organization, Nursing, Neurocritical Care Society, University of California Television, Diagnosis, Locked-in syndrome, Campaign, M-Systems, Neuroimaging, Caregiver, Ethics, Neurology, Stroke, Awareness, Zolpidem, Meningitis, MAS, ICU, Electroencephalography, Consciousness, Goal, Research, Pharmacist, Population, Chairperson, Physician, NDE, Medical device, Pharmaceutical industry, Medicine, Medical imaging, Liquor, MD

The Neurocritical Care Society (NCS) and the Curing Coma Campaign today announced the second annual World Coma Day , a 24-hour online global event, will commence on March 22, 2022.

Key Points: 
  • The Neurocritical Care Society (NCS) and the Curing Coma Campaign today announced the second annual World Coma Day , a 24-hour online global event, will commence on March 22, 2022.
  • Through research and growing awareness, we want coma to be recognized as a treatable and recoverable clinical condition.
  • The World Coma Day program will begin at 00:00 GMT (London time) on March 22 and continue for 24 hours; each session will be broadcast three different times during the day.
  • World Coma Day provides international perspectives of individuals and experts from around the world.

The Metaverse Gets a Boost: NexStem Announces the General Availability of Its Award-winning BCI Headsets That Control Devices Through Thought Alone 

Retrieved on: 
Wednesday, March 16, 2022
Science, Software, Research, Hardware, General Health, Health, Technology, Other Technology, Medtech, SDK, Electrode, Eye, Quality of life, Solution, Wi-Fi, Technology, Virtual reality, EEG, Mental health, Multimedia, Map, Wisdom, Graphics processing unit, Machine learning, Television, Brain, Mental, Algorithm, Internet, BCIS, Electroencephalography, CTO, Research, BCI, CEO, Growth, Heart, Interface (computing), Muscle, APAC, Robotics, Software, Medical imaging, Medical device, Video game console, VR

Recent research estimates that the global market for BCI devices will grow from $1.9 billion in 2021 to $3.3 billion by 2026.

Key Points: 
  • Recent research estimates that the global market for BCI devices will grow from $1.9 billion in 2021 to $3.3 billion by 2026.
  • Further accelerating this growth is the fact that BCI use cases are growing from rudimentary health and static virtual reality applications to more immersive all-encompassing experiences.
  • NexStem Wisdom SDK - The NexStem Wisdom SDK is a no-code modern, intuitive, and easy alternative to developing and designing BCI applications.
  • To help unlock the human brain and improve quality of life for all while inserting humankind into the metaverse, we think beyond thought.

American Aires Launches Video Series Demonstrating Product Efficacy

Retrieved on: 
Tuesday, March 8, 2022
EMR, Research, Internet, Publication, VR, Electronic oscillator, Wireless, OTCQB, Adoption, CSE, Mobile, Reading, Brain, WIFI, Science, Radiation, Electromagnetic radiation, Technology, CA, EMF, Computer, CEO, EMF measurement, Electroencephalography, Mobile phone, Medical imaging, Metaverse, LATAM Colombia

Toronto, Ontario--(Newsfile Corp. - March 8, 2022) - American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (the "Company" or "Aires"), a provider of scientifically-proven EMF modulation technology, launched their first video of a series demonstrating the effectiveness of the Aires microprocessor at eliminating the biological effects of radiation emitted from electronic devices.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - March 8, 2022) - American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (the "Company" or "Aires"), a provider of scientifically-proven EMF modulation technology, launched their first video of a series demonstrating the effectiveness of the Aires microprocessor at eliminating the biological effects of radiation emitted from electronic devices.
  • The second thing was just how clearly effective the Aires technology was at returning the brain to a calm baseline.
  • Although a date for the next video has not been announced, the Aires team says more are already in development.
  • American Aires Inc. is Canadian-based nanotechnology company which has developed proprietary silicon-based microprocessors that reduce the harmful effects of electromagnetic radiation (EMR).

Valued to be $33.4 Billion by 2026, Earphones and Headphones Slated for Robust Growth Worldwide

Retrieved on: 
Tuesday, February 22, 2022
Atmos, ECG, Pioneer Corporation, Sennheiser, Intelligence, COVID-19, Thermoregulation, Sport, Forecasting, Bose Corporation, Grado Labs, Apple Inc., Research, Harman International, Growth, Logitech, LLC, Heart rate, Blood pressure, SAN, Shure, CAGR, Electroencephalography, MP, Music, Players, GIA, Computer, Smartphone, Dolby Atmos, Internet, Panasonic, Sony, Virtual reality, Marketing, Wireless, Ultimate Ears, Mobile phone, Pet, Others, Headphones, Incorporated, Technology

We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies.

Key Points: 
  • We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies.
  • Preview Registry
    Earphones and headphones are sound accessories that are designed to receive audio signals to enable users to hear sound.
  • Headphones and earphones boast enhanced filtering for sound quality and are poised to benefit from ongoing efforts to further improve hearing quality for users.
  • This segment currently accounts for a 43.8% share of the global Earphones and Headphones market.

Super Bowl Advertising Receptivity Measured by Neuroscience

Retrieved on: 
Thursday, February 17, 2022
Health, Algorithm, Relaxation, Cognition, Learning, ASICS, Super Bowl, DOOH, Kansas City Chiefs, CTV, Brain, Weather, Electroencephalography, Super Bowl LVI, Tampa Bay Buccaneers, Football, SAN, Advertising, Keiiti Aki, 2020 Tampa Bay Buccaneers season, Goal, Technology, Emotion, Citizen science, Buccaneer, 2021–22 NCAA football bowl games, Publication, Super Bowl LV, Machine learning, Research, Dell, Reception report, 2020 Kansas City Chiefs season, EEG, Attention, Mobile phone, Toy

Aki today announced the first-of-its-kind study intended to measure advertising receptivity from panelists' brainwave activity in response to Super Bowl LVI advertisements and game outcomes.

Key Points: 
  • Aki today announced the first-of-its-kind study intended to measure advertising receptivity from panelists' brainwave activity in response to Super Bowl LVI advertisements and game outcomes.
  • For the four hours of Super Bowl LVI, panelists wore EMOTIV EEG headsets, which measured their brain wavesindicating stress, engagement, interest, excitement, focus and relaxation as they watched the game, commercials, and halftime performance.
  • During last year's Super Bowl LV, when the Kansas City Chiefs were defeated by the Tampa Bay Buccaneers, Kansas City's advertising receptivity averaged 6% lower than their baseline, according to Aki Technologies' 2021 campaign data.
  • The results of the Aki-Emotiv Super Bowl LVI Report will be published in March 2022 as part of Aki Technologies' annual Receptivity Report.

EQS-News: u-blox AG: Empowering chronic pain sufferers to reclaim their lives with technology

Retrieved on: 
Tuesday, February 15, 2022
Cloud, Neurofeedback, Patient, BCI, Scalp, Perception, Electronics, Brain, Solution, Brain–computer interface, Interface (computing), IOT, Clinical trial, OTC, Safety, Bluetooth, Internet, Technology, Pain, Axon, LinkedIn, Light, Twitter, Maintenance, Communication, Electrode, EEG, SIP, Chronic pain, Medical device, Medical imaging, Video game console, Electroencephalography, Facebook, u-blox, Exsurgo, U-BLOX, EXSURGO

Exsurgo's solution to alleviating chronic pain relies on neurofeedback, an approach that involves measuring a user's brain activity and providing them with state-specific feedback.

Key Points: 
  • Exsurgo's solution to alleviating chronic pain relies on neurofeedback, an approach that involves measuring a user's brain activity and providing them with state-specific feedback.
  • A massive burden on healthcare systems and the economy, chronic pain affects up to one in five people around the world.
  • Exsurgo's immediate focus is on a range of services involving EEG (short for Electroencephalography) Neurofeedback, a long-established, non-invasive, drug-free therapy for a wide range of neurological conditions including chronic pain.
  • The Axon headset is a custom-designed EEG headset (a Brain Computer Interface or BCI) that passively reads the bio-electrical activity associated with pain in the patient's brain.